Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
McKinsey
Chubb
Federal Trade Commission
Farmers Insurance
Healthtrust
Daiichi Sankyo
US Department of Justice
QuintilesIMS

Generated: April 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 207920

« Back to Dashboard

NDA 207920 describes NEXIUM 24HR, which is a drug marketed by Astrazeneca Lp and is included in two NDAs. It is available from two suppliers. There are three patents protecting this drug and one Paragraph IV challenge. Additional details are available on the NEXIUM 24HR profile page.

The generic ingredient in NEXIUM 24HR is esomeprazole magnesium. There are seventy drug master file entries for this compound. Sixty-three suppliers are listed for this compound. Additional details are available on the esomeprazole magnesium profile page.
Summary for 207920
Tradename:NEXIUM 24HR
Applicant:Astrazeneca Lp
Ingredient:esomeprazole magnesium
Patents:3
Therapeutic Class:Gastrointestinal Agents
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 207920
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NEXIUM 24HR esomeprazole magnesium TABLET, DELAYED RELEASE;ORAL 207920 NDA Wyeth Consumer Healthcare LLC 0573-2451 N 0573-2451-14
NEXIUM 24HR esomeprazole magnesium TABLET, DELAYED RELEASE;ORAL 207920 NDA Wyeth Consumer Healthcare LLC 0573-2451 N 0573-2451-42

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:TABLET, DELAYED RELEASE;ORALStrengthEQ 20MG BASE
Approval Date:Nov 23, 2015TE:RLD:Yes
Patent:➤ Sign UpPatent Expiration:Nov 25, 2018Product Flag?Substance Flag?Delist Request?Y
Patent:➤ Sign UpPatent Expiration:May 3, 2020Product Flag?Substance Flag?Delist Request?Y
Patent:➤ Sign UpPatent Expiration:Nov 18, 2018Product Flag?Substance Flag?Delist Request?Y

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Harvard Business School
Colorcon
Fuji
Cerilliant
Accenture
Chubb
Argus Health
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.